Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now There are no microchips in Huggies diapers ...

Kleenex tissues are a Kimberly-Clark brand. Just over half of the company’s revenue comes from outside North America. File 2011 / FThe Associated Press Michael Hsu will succeed Thomas Falk as chief ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

Our thoughts are with all those affected by the devastating wildfires in California, including our employees and their loved ones who live and work in these communities. To support relief efforts in ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at household products stocks, starting with ...